Role of Mineralocorticoids in Hypertension
盐皮质激素在高血压中的作用
基本信息
- 批准号:8896013
- 负责人:
- 金额:$ 28.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1980
- 资助国家:美国
- 起止时间:1980-09-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdrenal CortexAdrenal GlandsAdrenal MedullaAdultAffectAldosteroneAldosterone SynthaseAnabolismAngiotensin IIAngiotensinsAnimal ModelAnimalsAreaAxillaBenignBilateralBlood PressureCYP11B2 geneCa(2+)-Transporting ATPaseCalcium ChannelCardiovascular DiseasesCardiovascular systemCell LineCellsCholesterolChronicCircadian RhythmsCorticosteroneDevelopmentDiagnosisDietDiet ModificationEnzymesEssential HypertensionExposure toGene Expression ProfileGene MutationGenerationsGenesGlandGrowthHealthHumanHuman Cell LineHyperaldosteronismHyperplasiaHypertensionImmunohistochemistryIn SituIntakeKidneyMeasurementMeasuresMediatingMineralocorticoidsMitochondriaModelingMolecularMusMutationNa(+)-K(+)-Exchanging ATPaseNeuropeptide ReceptorNeurotransmittersObesityObstructive Sleep ApneaPathway interactionsPatientsPhenotypePlasmaPlayPotassium ChannelProductionRattusRegulationReninRenin-Angiotensin SystemRoleSamplingSecondary HypertensionSiteSodiumSodium ChlorideSodium-Restricted DietSomatic MutationSomatostatinSpecimenSteroid biosynthesisSteroidsSystemTestingTissuesTranscriptional RegulationTransplantationZona Glomerulosaadenomabasecapsulecerebrovascularhuman subjecthuman tissuelaser capture microdissectionlow renin hypertensionnerve supplyneuroregulationreceptorrelating to nervous systemsteroidogenic acute regulatory proteintooltranscriptome sequencingtranslational approachtumor
项目摘要
DESCRIPTION (provided by applicant): Primary Aldosteronism (PA) is the most common form of secondary hypertension, affecting 4-14% of those with high blood pressure. PA is associated with a significantly greater increase in cardiovascular and cerebrovascular than patients with essential hypertension with a similar increase and duration of hypertension. Two pathological diagnoses comprise about 98% PA: Idiopathic hyperaldosteronism (IHA) characterized by increased aldosterone synthesis by both adrenals and responsible for 30-70% of PA, and benign aldosterone- producing adenomas (APA). While several gene mutations have been identified in APAs, the cause of IHA is unknown. Neither genetic changes nor changes in known aldosterone (aldo) stimulating factors have been found in IHA patients. We propose to address the following hypothesis: "Idiopathic hyperaldosteronism is in part neurally mediated" and "neural modulation of aldosterone biosynthesis is important and can be explored in surrogate animals." This translational proposal will use human adrenal samples, a human adrenal cortical cell line in culture, and rat models as surrogates to tease out possible mechanisms for IHA. Chronic low sodium maximally stimulates zona glomerulosa growth and aldo synthesis. Acute sodium repletion rapidly suppresses aldo release before the disappearance of rate-limiting enzymes for its synthesis. Specific Aim 1 will characterize the role
of adrenal zona glomerulosa innervation from the adrenal medulla and capsule in the regulation of aldosterone secretion and zona glomerulosa remodeling. Rats with intact adrenals, enucleated in situ (medulla and much of the zonas reticularis/fasciculata removed, remaining neural connections to the capsule intact) and enucleated adrenals transplanted into the axilla will be studied after chronic low sodium intake followed by acute voluntary sodium replenishment to distinguish between humoral and neural control. The hypothesis that somatostatin synthesized within the adrenal medulla mediates adrenal suppression upon sodium repletion will be tested. Adrenals of adult humans have clusters of cells that express aldosterone synthase (CYP11B2 enzyme) abundantly amid quiescent ZG cells called aldosterone-producing cell clusters (APCC). Rats on a chronic high salt diet have similar APCC. Exposure to multiple cycles of chronic low sodium intake followed by sodium repletion will be studied to determine if these APCC become larger and/or aldo production becomes autonomous, leading to an IHC phenotype including hypertension in the rats. Transcriptome studies of zona glomerulosa samples of rats on a high sodium diet dissected by laser capture microdissection. Samples rich in clusters of cells expressing high levels of the aldosterone synthase will be compared with quiescent areas. Primary tools will be the measurement of the expression of steroids and genes involved in the control of steroidogenesis, including neurotransmitters know to be present in the adrenal cortex, and immunohistochemistry. We will also study the intrinsic innervation and expression of neuropeptides and receptors, as well as factors discovered in the RNAseq transcriptome studies, in normal human adrenals and those from patients with APA and IHA and correlate our findings from the human subjects with those of the rat models. The aim is to discover how aldosterone synthesis is actively suppressed under normal conditions and whether these mechanisms are defective in IHA and in the adrenal glomerulosa tissues surrounding the adenoma in APA which is often active despite high aldosterone and low renin/angiotensin levels.
描述(由申请人提供):原发性醛固酮(PA)是次要高血压的最常见形式,影响高血压的人中有4-14%。 PA与具有高血压的基本高血压患者相比,心血管和脑血管脑血管的增长明显更大,高血压的增加和持续时间。两种病理诊断约为98%PA:特发性大甲醛酸(IHA)(IHA),其特征是肾上腺的醛固酮合成增加,负责30-70%的PA和良性醛固酮产生腺苷(APA)。尽管在APA中已经鉴定出了几个基因突变,但IHA的原因尚不清楚。 IHA患者均未发现遗传变化或已知醛固酮(ALDO)刺激因子的变化。我们建议解决以下假设:“特发性高醛源性部分是神经介导的”和“醛固酮生物合成的神经调节很重要,可以在替代动物中探索。”该翻译建议将使用人类肾上腺样本,培养中人类肾上腺皮质细胞系,而大鼠模型则作为替代品,以取消IHA的可能机制。慢性低钠最大刺激Zona肾小球生长和Aldo合成。急性钠的补充会在限制酶的合成之前迅速抑制Aldo释放。特定目标1将表征角色
在醛固酮分泌和Zona glomerulosa重塑的调节中,从肾上腺髓质和胶囊肾上腺肾小球神经支配进行。具有完整肾上腺的大鼠,塞核的原位(髓质和大部分叶片网状/fasciculata被移除,剩余的神经连接到胶囊完整),并在慢性低硫化含量后,将在慢性低硫化后进行良好的自发性控制后,将被移植到腋窝中的in核肾上腺。将测试肾上腺髓质中合成的生长抑素合成的假说将测试钠的肾上腺抑制。成年人类的肾上腺具有表达醛固酮合酶(CYP11B2酶)的细胞簇,在称为产生醛固酮的细胞簇(APCC)的静止的ZG细胞中。慢性高盐饮食的大鼠具有相似的APCC。将研究暴露于多个慢性低钠摄入量的循环,然后研究钠含量,以确定这些APCC是否变得更大,并且/或Aldo产生自治,从而导致IHC表型,包括大鼠的高血压。通过激光捕获显微解剖解剖的高钠饮食中大鼠zona肾小球样品的转录组研究。将富含表达高水平醛固酮合酶的细胞簇的样品与静态区域进行比较。主要工具将是测量与控制类固醇生成的类固醇和基因的表达,包括神经递质已知存在于肾上腺皮质中,以及免疫组织化学。我们还将研究神经肽和受体的固有神经和表达,以及在正常人类肾上腺中的RNASEQ转录组研究中发现的因素,以及来自APA和IHA患者的肾上有神经支配和表达,并将人类受试者的发现与大鼠模型相关。目的是发现醛固酮合成如何在正常条件下积极抑制,以及这些机制在IHA和APA腺瘤周围的肾上腺肾小球组织中是否有缺陷,APA中的肾上腺肾小球组织是否经常活跃,尽管醛固酮高和肾素较低/血管素/血管紧张素水平。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Celso Enrique Gomez-Sanchez其他文献
Celso Enrique Gomez-Sanchez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Celso Enrique Gomez-Sanchez', 18)}}的其他基金
Regulation of Mineralocorticoid Receptor Action
盐皮质激素受体作用的调节
- 批准号:
10553631 - 财政年份:2020
- 资助金额:
$ 28.26万 - 项目类别:
Regulation of Mineralocorticoid Receptor Action
盐皮质激素受体作用的调节
- 批准号:
10293532 - 财政年份:2020
- 资助金额:
$ 28.26万 - 项目类别:
Regulation of Mineralocorticoid Receptor Action
盐皮质激素受体作用的调节
- 批准号:
10436926 - 财政年份:2020
- 资助金额:
$ 28.26万 - 项目类别:
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
肾上腺细胞ATP1A1突变与醛固酮生物合成机制
- 批准号:
9981536 - 财政年份:2019
- 资助金额:
$ 28.26万 - 项目类别:
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
肾上腺细胞ATP1A1突变与醛固酮生物合成机制
- 批准号:
10447775 - 财政年份:2019
- 资助金额:
$ 28.26万 - 项目类别:
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
肾上腺细胞ATP1A1突变与醛固酮生物合成机制
- 批准号:
9813129 - 财政年份:2019
- 资助金额:
$ 28.26万 - 项目类别:
Adrenal cell ATP1A1 mutations and mechanisms of aldosterone biosynthesis
肾上腺细胞ATP1A1突变与醛固酮生物合成机制
- 批准号:
10210433 - 财政年份:2019
- 资助金额:
$ 28.26万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
- 批准号:
10659658 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
An Inhaled Microbiome-Targeted Biotherapeutic for Treatment of COPD
一种吸入性微生物组靶向生物治疗药物,用于治疗慢性阻塞性肺病
- 批准号:
10600887 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
A Mixed Methods Evaluation of Developing COPD Exacerbations in the MARC Cohort
MARC 队列中 COPD 加重的混合方法评估
- 批准号:
10605385 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别:
Development of Patient-Tailored Adaptive Treatment Strategies for Acute Severe Ulcerative Colitis
制定针对急性重症溃疡性结肠炎的患者定制适应性治疗策略
- 批准号:
10569397 - 财政年份:2023
- 资助金额:
$ 28.26万 - 项目类别: